Algorae Pharmaceuticals
@algoraepharma
Algorae Pharmaceuticals (#ASX: #1AI) is a pharmaceutical R&D company developing novel treatments for debilitating conditions including #Dementia
You might like
Algorae (#ASX Code #1AI) April 2024 non-deal corporate presentation (#AI #artificialintelligence). Click here for presentation: announcements.asx.com.au/asxpdf/2024041…
Algorae Pharmaceuticals Limited (#ASX: #1AI) is delighted to announce the launch of AlgoraeOS Ver. 2 - a major upgrade to Algorae’s #AI drug discovery platform. Read here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals Driving Expansion with Innovation and Commercialisation @algoraepharma #1AI $1AI new.smallcaps.com.au/article/algora…
Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae September 2025 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #AI #biotech #FDA #TGA Read here: stocknessmonster.com/announcements/…
AI-enabled pharmaceutical company @algoraepharma (ASX: 1AI) has appointed David Gulland as its new Chief Operating Officer (COO), effective March 2026. With over 20 years of experience in healthcare funding, pharmacy services, and digital transformation, David will lead…
@algoraepharma (ASX: 1AI) signs deal with Cadila Pharmaceuticals to launch two generic medicines in Australia and NZ. Regulatory prep underway. Read more: techinvest.online/news/algorae-p… #ASX #1AI #Pharma #Healthcare #Cadila #Biotech #DrugDevelopment
Algorae Pharmaceuticals (#1AI : #ASX) is pleased to announce its new partnership with @Cadila_Pharma to launch two medicines into the ANZ markets - expanding its commercial footprint. Read here: stocknessmonster.com/announcements/…
Algorae (#ASX: #1AI) is delighted to announce the appointment of Mr David Gulland as COO. Mr Gulland was former General Manager of HPS Pharmacies, a $500M national franchise servicing hospitals, and a division of EBOS Group $EBO. Read here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals (#ASX: #1AI) is delighted to announce an exclusive commercial licensing agreement with Sakar Healthcare (NSE: $SAKAR) to launch five (5) generic oncology medicines into Aus/NZ markets with addressable market A$10M/annum. Read here: stocknessmonster.com/announcements/…
The AI drug discovery opportunity Australia must seize capitalbrief.com/article/the-ai…
Algorae is seeking a COO to join our dynamic, high-growth organisation. Link below. linkedin.com/jobs/view/4278…
Algorae Pharmaceuticals (#ASX Code: #1AI) Receives A$318,771 R&D Cash Rebate from ATO. Read here: stocknessmonster.com/announcements/…
Algorae (#ASX #1AI) announces that it has partnered with the prestigious Peter Macallum Cancer Centre to evaluate 24 wholly owned drug targets, 21 of which were generated by the AlgoraeOS #ArtificialIntelligence drug discovery platform. Read more here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae March 2025 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #CBD #AI #dementia #cardiovascular #biotech #FDA Read here: stocknessmonster.com/announcements/…
I’m thrilled to announce the appointment of Vishal Shah as our Chief Commercial Officer. Algorae will continue to focus on recruiting the best talent in Australia to execute our corporate strategy. Thank you to our loyal shareholder base. #1AI @algoraepharma
Algorae Pharmaceuticals (#ASX: #1AI) #ASXNews: Algorae Strengthens Leadership Team with Appointment of Vishal Shah as Chief Commercial Officer. Read here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals (#ASX: #1AI) #ASXNews: Algorae Strengthens Leadership Team with Appointment of Vishal Shah as Chief Commercial Officer. Read here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals (#ASX: #1AI) #ASXNews: Algorae Receives A$451,359 R&D Cash Rebate to be allocated to R&D and the pursuit of early revenue opportunities, where feasible. Read here: stocknessmonster.com/announcements/…
Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae December 2024 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #CBD #AI #dementia #cardiovascular #biotech #FDA Read here: stocknessmonster.com/announcements/…
United States Trends
- 1. #CashAppGreen N/A
- 2. hayley 16.3K posts
- 3. Bubba 18.4K posts
- 4. Rondo 2,441 posts
- 5. #FanCashDropPromotion 3,219 posts
- 6. Wale 43.7K posts
- 7. Bill Clinton 89.6K posts
- 8. Hunter Biden 13.8K posts
- 9. Summer Walker 34.8K posts
- 10. #FursuitFriday 13.5K posts
- 11. Bart Scott N/A
- 12. #Talus_Labs N/A
- 13. Ticketmaster 9,298 posts
- 14. #FridayVibes 6,979 posts
- 15. Hilary Duff 2,697 posts
- 16. Reid Hoffman 28.4K posts
- 17. Thomas Crooks 54.8K posts
- 18. Jaylon Johnson 1,415 posts
- 19. Morocco 118K posts
- 20. Vatican 12.4K posts
You might like
-
Cardiex Limited
@CardiexLimited -
Stuart Biddle
@stuart_biddle -
Mark Hirsch
@MarkAHirsch -
Robin Hicks
@RobinHicks_ -
Race Oncology
@RaceOncology -
AnteoTech Ltd
@AnteoTech_ -
THETA GOLD MINES
@ThetaGoldMines -
Paul Tweed
@Paul_Tweed -
Cynata Therapeutics
@cynatastemcells -
Herestothefuture
@LilliandTerry83 -
BCAL Diagnostics
@bcal_dx -
@stefanietulloch on BlueSky
@StefanieTulloch -
Immutep
@Immutep -
Orthocell Ltd
@OrthocellLtd -
Michael Werner
@Mindtrekker
Something went wrong.
Something went wrong.